Gottlieb Touts New FDA Science Office, Push for Generic Approvals in 2019

Drug Industry Daily
As the partial government shutdown kept the FDA’s routine activities on hold, FDA Commissioner Scott Gottlieb on Tuesday announced the creation of a new office to help streamline the agency’s review of new drugs.

To View This Article:


Subscribe To Drug Industry Daily